Mar. 13, 2008—Cancer patients from the Southeastern United States who are treated with the drug cetuximab, known commercially as Erbitux, are far more likely to suffer severe allergic reactions than patients in other regions of the country.
Mar. 7, 2008—When your mother told you to eat your vegetables it appears that maternal wisdom had a scientific basis. Researchers with Vanderbilt-Ingram Cancer Center and the Shanghai Cancer Institute in China have discovered a possible link between a diet rich in certain vegetables and a decreased risk for breast cancer. The study appears in the March issue of the American Journal of Clinical Nutrition.
Jan. 17, 2008—Jennifer Pietenpol, Ph.D., Ingram Professor of Cancer Research and professor of Biochemistry, has been named director of Vanderbilt-Ingram Cancer Center.
New review clears silicone gel breast implants of serious health risks; Vanderbilt-Ingram Cancer Center researchers find no cancer link
Oct. 25, 2007—Women who receive silicone gel-filled breast implants do not have a higher risk of breast cancer or other cancers and do not experience lower survival rates after breast cancer diagnosis, according to a new report published in the November issue of Annals of Plastic Surgery. This is the first exhaustive review in almost a decade of the health effects of cosmetic breast implants.
Prostate cancer patients may be eligible for less invasive therapy; Vanderbilt-Ingram Cancer Center first in state to test new ultrasound procedure
Aug. 29, 2007—Men with prostate cancer now may have access to a new, minimally invasive surgical procedure. Urologic surgeons at Vanderbilt-Ingram Cancer Center will be the first in Tennessee to test the new Ablatherm procedure, which uses high-intensity focused ultrasound (HIFU) to destroy cancerous prostate tissue without any incision.
Feb. 23, 2007— When the dust settles on a new renovation project involving Vanderbilt-Ingram Cancer Center‘s Henry-Joyce Cancer Clinic, waiting room space and exam rooms will nearly double to help meet the needs of an ever increasing number of cancer patients in Middle Tennessee and beyond.
Feb. 22, 2007— Vanderbilt-Ingram Cancer Center has received a three-year accreditation with commendation, the highest level of approval, from the Commission on Cancer of the American College of Surgeons (ACoS).
Jan. 29, 2007— Like a seed needs soil to grow and flourish, a tumor relies on its environment to grow and spread in the body -- something the Vanderbilt-Ingram Cancer Center will be exploring more closely with the help of a new $6.5 million grant from the National Cancer Institute (NCI).
Jan. 29, 2007— Jennifer A. Pietenpol, Ph.D., has been selected to lead the Vanderbilt-Ingram Cancer Center as interim director.
Jan. 10, 2007— Raymond DuBois Jr., M.D., Ph.D., will leave his position as director of the Vanderbilt-Ingram Cancer Center later this year to return to his native Texas as provost and executive vice president of academic affairs at M.D. Anderson Cancer Center in Houston.
‘Project HealthDesign‘ Awards Vanderbilt University Medical Center $300,000 Grant to Design and Test Innovative, Consumer-Centered PHR Applications
Dec. 14, 2006— Vanderbilt University Medical Center has been selected as one of nine teams nationwide to participate in a landmark program from the Robert Wood Johnson Foundation (RWJF) to design and test bold ideas for how consumers can use information technology to better manage their health and navigate the health care system.
Dec. 12, 2006— Vanderbilt University Medical Center has received a five-year, $1 million grant from the National Foundation for Cancer Research (NFCR) to apply the powerful science of proteomics to drug discovery.